Is BELLUS Health Inc. (BLU) a Buy, Sell, or Hold?
NASDAQ : BLU
BELLUS Health Inc.
$14.745 USD
$0.01 (0.03%)
- Volume
- 2.84M
- Average Volume
- 2.9M
- Market Capitalization
- $1.87B
- P/E Ratio
- -22.34
- Dividend Yield
- 0.00%
- Price Target
- $14.75
- Year High
- $14.76
- Year Low
- $6.38
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $22.42
Company Overview
NASDAQ
Roberto Francesco Bellini
Biotechnology
Healthcare
BLU
74
CA
USD
Liquidity Metrics
0.00
22.42
22.42
5.50
0.00
Sales & Valuation
$16000
116865.18
4.35
-19.08
-0.85
Profitability
-$0.66
-$76.08M
-475500.00%
-475125.00%
-22.28%
-18.66%
P/E Metrics
-22.34
-0.86
-0.86
Analyst Price Target & Rating
$14.75
$14.75
$14.75
0/5
6 Analysts
-0.03%
Financial Health Scores
1.36
3/9
$890.08M
$3.09B
$1.91B
-$150.28M
Key Metrics (TTM)
$1.78B
111492.25
-24.52
22.42
-22.28%
-19.85%
-4.47%
-5.24%
37480 days
Company Executives
| Name | Title |
|---|---|
| Denis Garceau | Chief Scientific Officer |
| Tony Matzouranis | Chief Bus. Officer |
Poll Results
No votes yet today — be the first to share your view!
About BELLUS Health Inc. (NASDAQ:BLU) Stock
BELLUS Health Inc. is a clinical-stage biopharmaceutical company headquartered in Laval, Canada, and founded in 1993. The firm focuses on developing therapeutic solutions for refractory chronic cough (RCC) and other related cough hypersensitivity conditions. Its leading product candidate, BLU-5937, an antagonist designed to block the P2X3 receptor, is currently progressing through Phase II clinical trials for the treatment of both RCC and chronic pruritus. ...
2026-07-23 15:45:00
VANCOUVER, BC, July 23, 2026 /PRNewswire/ - BluEnergies Ltd. (TSXV: BLU) (OTCQX: BLUGF) (F: 66E) ("BLU" or the "Company") is pleased to announce that, further to its news releases dated July 9, 2026 and July 21, 2026, it has closed its previously announced non-brokered private placement (the "Offering").
Frequently Asked Questions
-
What is the current BELLUS Health Inc. (BLU) stock price?
-
BELLUS Health Inc.(NASDAQ:BLU) stock price is $14.745 in the last trading session. During the trading session, BLU stock reached the peak price of $14.76 while $6.38 was the lowest point it dropped to. The percentage change in BLU stock occurred in the recent session was 0.03% while the dollar amount for the price change in BLU stock was $0.01.
-
BLU's industry and sector of operation?
-
The NASDAQ listed BLU is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of BLU?
-
Denis Garceau | Chief Scientific Officer
Tony Matzouranis | Chief Bus. Officer
|
|
| -
How many employees does BLU have?
-
Number of BLU employees currently stands at 74. BLU operates from 275 Armand-Frappier Boulevard, Laval, QC H7V 4A7, CA.
-
Link for BLU official website?
-
Official Website of BLU is: https://gsk.com
-
How do I contact BLU?
-
BLU could be contacted at phone #14506804500 and can also be accessed through its website. BLU operates from 275 Armand-Frappier Boulevard, Laval, QC H7V 4A7, CA.
-
How many shares of BLU are traded daily?
-
The average number of BLU shares traded daily for last 3 months was 2.9M.
-
What is the market cap of BLU currently?
-
The market value of BLU currently stands at $1.87B with its latest stock price at $14.745